Search hospitals > Georgia > Atlanta
Atlanta Center for Medical Research
Claim this profileAtlanta, Georgia 30331
Global Leader in Schizophrenia
Global Leader in Depression
Conducts research for Major Depressive Disorder
Conducts research for Alzheimer's Disease
Conducts research for Attention Deficit Hyperactivity Disorder (ADHD)
219 reported clinical trials
3 medical researchers
Summary
Atlanta Center for Medical Research is a medical facility located in Atlanta, Georgia. This center is recognized for care of Schizophrenia, Depression, Major Depressive Disorder, Alzheimer's Disease, Attention Deficit Hyperactivity Disorder (ADHD) and other specialties. Atlanta Center for Medical Research is involved with conducting 219 clinical trials across 120 conditions. There are 3 research doctors associated with this hospital, such as Maria Johnson, MD, Robert Riesenberg, MD, and R RIESENBERG.Top PIs
Maria Johnson, MDAtlanta Center for Medical Research3 years of reported clinical research
Studies Schizophrenia
Studies Depression
8 reported clinical trials
9 drugs studied
Robert Riesenberg, MDAtlanta Center for Medical Research1 year of reported clinical research
Studies Major Depressive Disorder
Studies Depression
4 reported clinical trials
7 drugs studied
R RIESENBERGAtlanta Center of Medical Research1 year of reported clinical research
Studies Obesity
1 reported clinical trial
2 drugs studied
Clinical Trials running at Atlanta Center for Medical Research
Bipolar Disorder
Autism Spectrum Disorder
Schizophrenia
Sickle Cell Anemia
Major Depressive Disorder
Autism
Sickle Cell Disease
Parkinson's Disease
Depression
Obesity
Cariprazine
for Pediatric Schizophrenia
This trial is testing the safety and effectiveness of cariprazine in children and teens with schizophrenia, bipolar I disorder, or autism. The goal is to see if the medication is safe and beneficial for use in these young patients.
Recruiting2 awards Phase 32 criteria
Cariprazine
for Bipolar Disorder in Youth
Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United States. The treatment of the depressive episodes of bipolar disorder in the pediatric population has not been as widely studied as the treatment of depressive episodes in bipolar disorder in adults, therefore pharmacotherapeutic options are limited. Given the change in disease state and safety demonstrated in adults with depressive episodes associated with bipolar I disorder, the purpose of this study is to evaluate the change in disease state and safety of cariprazine in the treatment of depressive episodes associated with bipolar I disorder in the pediatric population. Cariprazine is an approved drug for the treatment of depressive episodes in adult participants with bipolar I disorder. Study doctors put participants in 1 of 2 groups, called treatment arms. There is a 1 in 2 chance that a participant will be assigned to placebo. Around 380 Participants ages 10-17 years with bipolar I disorder will be enrolled in approximately 60 sites worldwide. Participants receiving the study drug will receive Dose A or B of Cariprazine based on age and weight. At Week 3, participants with insufficient response will have their dose increased to Dose B or Dose C, while participants with sufficient response will continue receiving the Dose A or B for the remainder of the treatment period. The treatment period will be followed by a safety follow-up (SFU) period for 4 weeks. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular weekly visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
Recruiting1 award Phase 33 criteria
BHV-7000
for Bipolar Disorder
The purpose of this study is to determine whether BHV-7000 is a safe and effective acute treatment for manic episodes in bipolar disorder I.
Recruiting0 awards Phase 2 & 33 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Atlanta Center for Medical Research?
Atlanta Center for Medical Research is a medical facility located in Atlanta, Georgia. This center is recognized for care of Schizophrenia, Depression, Major Depressive Disorder, Alzheimer's Disease, Attention Deficit Hyperactivity Disorder (ADHD) and other specialties. Atlanta Center for Medical Research is involved with conducting 219 clinical trials across 120 conditions. There are 3 research doctors associated with this hospital, such as Maria Johnson, MD, Robert Riesenberg, MD, and R RIESENBERG.